Click here for more information about Algenuity
Click here for more information about Liqofluxphenometrics515R1
Visit cricatalyst.com!Evodos Separation Technology Check out more of The Buzz spacer

Dr. Craig Behnke joins Lumen Bioscience as SVP

July 16, 2018
AlgaeIndustryMagazine.com

Dr. Craig Behnke has joined Lumen Bioscience as Senior Vice President, Production and Development.

Lumen Bioscience, a Seattle company developing novel biologics on its proprietary spirulina expression platform, has announced that Dr. Craig Behnke has joined its executive team as Senior Vice President, Production and Development.

Dr. Behnke will assume leadership of Lumen’s existing production and development teams. He joins as Lumen launches its first product, RioBlue™, a high-purity protein extract used as a blue colorant by the food and cosmetics industries. Dr. Behnke previously served as Vice President of Research and Development at Sapphire Energy in San Diego, a pioneer in the industrial-scale cultivation of photosynthetic microbes.

“We are pleased to welcome Dr. Behnke to Lumen’s senior leadership team,” said Brian Finrow, Lumen’s CEO and co-founder. “Craig’s experience makes him the perfect leader to scale commercial production beyond our current facility in Seattle. His scientific background and history of scaling up biological systems at Sapphire will be invaluable as we continue to expand our capacity.”

Used first as a nutritional supplement for its naturally high protein, vitamin and antioxidant content, US spirulina extract sales soared after 2014 when the FDA approved it for use as a natural food colorant. Today it remains the only approved natural blue food pigment in the US, and is used mainly as a natural alternative to FD&C Blue #1, an artificial food colorant that is synthesized from petroleum.

“I am thrilled to be joining such a talented group of scientists, engineers, and quality professionals,” Dr. Behnke said. “This team has built a robust, integrated, cGMP-compliant production system to produce the highest possible quality product. They’ve laid a great foundation as we look to scale production to meet global demand over the next 24-36 months. Over the course of my career I have had the good fortune to participate in some remarkable achievements in bio-process yield improvement, and I’m excited to help unlock the enormous commercial potential of this fascinating new platform.” Dr. Behnke holds a Ph.D. in Biochemistry from the University of Washington and an M.S. in Biochemistry from Kansas State.

In addition to its core colorants business, Lumen has also won research funding to use its new platform to develop ultra-low-cost biologic drugs and vaccines, all of which rely upon the same integrated, FDA cGMP production platform. In May, the National Institutes of Health awarded Lumen a grant to continue developing its oral malaria vaccine, and last month Lumen announced additional research funding from the United States Department of Agriculture and the Bill & Melinda Gates Foundation for other vaccine and antibody research programs.

More Buzz…

Copyright ©2010-2018 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives

From The A.I.M. Archives

— Refresh Page for More Choices
Monica Jain of Fish 2.0 writes in National Geographic about how the algae brand is about to undergo an image makeover, and may soon seem flat-out glamorous — once again. ...
The recent announcement by the U.S. Department of Energy (DOE) of three projects to receive up to $8 million, aimed at reducing the costs of producing algal biofuels and ...
Carlsbad-based Surftech, a stand-up paddle (SUP) and Surfboard manufacturing company has announced its collaboration with BLOOM, a materials development company, to devel...
Washington State University researchers have developed a biofilm reactor to grow algae more efficiently, and make the algae more viable for several industries, including ...
Memory Maninga reports for Zambia Daily Mail that in Mansa, the capital of the Luapula Province of Zambia, spirulina is being grown in ponds in the communities because of...
Cyanotech Corporation a leader in microalgae-based, high-value nutrition and health products, announced financial results for the third quarter and first nine months of f...
42 Technology has been appointed by LabXero, acoustic particle filtration technology company, to help develop pilot-scale biomanufacturing equipment that could significan...
The Natural Algae Astaxanthin Association (NAXA), headquartered in Spring, Texas, has announced that Chile-based Atacama Bio is its newest executive member. Atacama Bio h...
Israeli-based Algatechnologies, Ltd. (Algatech) has become the major shareholder in Supreme Health New Zealand, Ltd. (Supreme) to supply the rapidly growing markets in Ch...
Judith Lewis Mernit writes in e360.yale.edu that an experiment being conducted by animal science professor Ermias Kebreab at the University of California, Davis, is testi...
Cécile Barbière writes for Euractive.fr (translated by Rob Kirby) that, in large greenhouses formerly home to the tomatoes and cucumbers of the market gardening Groupe Ol...
Alexander Richter reports for Geothermal Energy News that, among the many examples offered during a recent conference in Pisa, Italy, on Perspectives and Impact of the Gr...